垂体功能减退女性的生育与妊娠:系统文献综述
患者常需辅助生殖治疗,妊娠率47%至100%,活产率61%至100%。结论指出文献稀缺但达成妊娠者活产率高,需前瞻性研究评估治疗模式与结局关系。
要点
- 垂体功能减退女性常需辅助生殖治疗,妊娠率47%~100%,活产率61%~100%。
- 糖皮质激素、左甲状腺素和去氨加压素可在妊娠期安全使用。
- 生长激素治疗方案各国差异显著,部分文献支持对求生育女性有积极效应。
核心结论
- 垂体功能减退女性文献稀缺,但达成妊娠者活产率高(61%~100%)。
- 需前瞻性研究评估治疗模式与结局的关系。
- 替代治疗应始终模拟正常生理,妊娠进展中需求变化使管理具挑战性。
研究设计与样本
- 系统PubMed文献综述,检索1969至2019年,关键词为生育与垂体功能减退、妊娠与垂体功能减退、诱导排卵与垂体功能减退。
- 排除仅含2例患者/4次妊娠以下的病例报告或单病例系列。
主要发现
- 垂体功能减退女性常需辅助生殖治疗,妊娠率范围47%至100%。
- 达成妊娠的患者活产率范围61%至100%。
- 糖皮质激素、左甲状腺素和去氨加压素在妊娠期可安全处方。
- 生长激素治疗方案各国差异显著,多篇出版物支持对求生育女性有积极效应。
关键数值与推荐
- 妊娠率范围47%至100%(垂体功能减退女性,常需辅助生殖治疗)。
- 活产率范围61%至100%(达成妊娠的垂体功能减退患者)。
临床怎么用
- 垂体功能减退女性应评估生育需求,必要时提供辅助生殖治疗。
- 妊娠期糖皮质激素、左甲状腺素和去氨加压素可安全使用。
- 生长激素治疗需考虑各国方案差异,部分证据支持对求生育女性有益。
- 替代治疗应模拟正常生理,随妊娠进展调整以满足变化的需求。
局限性
- 需前瞻性研究评估结局与治疗模式的关系。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Human reproduction is mainly governed from the hypothalamic-adrenal-gonadal (HPG) axis, which controls both ovarian morphology and function. Disturbances in the secretion of other anterior pituitary hormones (and their respective endocrine axes) interfere with HPG activity and have been linked to fertility problems. In normal pregnancy, maintenance of homeostasis is associated with continuous changes in pituitary morphology and function, which need to be considered during hormone replacement in patients with hypopituitarism. DESIGN: We conducted a systematic PubMed literature review from 1969 to 2019, with the following keywords: fertility and hypopituitarism, pregnancy and hypopituitarism, and ovulation induction and hypopituitarism. Case reports or single-case series of up to 2 patients/4 pregnancies were excluded. RESULTS: Eleven publications described data on fertility (n = 6) and/or pregnancy (n = 7) in women with hypopituitarism. Women with hypopituitarism often need assisted reproductive treatment, with pregnancy rates ranging from 47% to 100%. In patients achieving pregnancy, live birth rate ranged from 61% to 100%. While glucocorticoids, levothyroxine, and desmopressin are safely prescribed during pregnancy, growth hormone treatment regimens vary significantly between countries, and several publications support a positive effect in women seeking fertility. CONCLUSIONS: In this first systematic review on fertility, ovulation induction, and pregnancy in patients with hypopituitarism, we show that while literature is scarce, birth rates are high in patients achieving pregnancy. However, prospective studies are needed for evaluating outcomes in relationship to treatment patterns. Replacement therapy in hypopituitarism should always mimic normal physiology, and this becomes challenging with changing demands during pregnancy evolution.
引用
- Vila G, Fleseriu M. Fertility and Pregnancy in Women With Hypopituitarism: A Systematic Literature Review. J Clin Endocrinol Metab. 2020. PMID: 31652320. doi:10.1210/clinem/dgz112
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。